GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$454M
AUM Growth
+$70.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$18.9M
2
+$17.6M
3
+$14.4M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$13.8M
5
MACK
Merrimack Pharmaceuticals, Inc.
MACK
+$10.4M

Top Sells

1
+$17.1M
2
+$11.1M
3
+$8.82M
4
PLXP
PLx Pharma Inc. Common Stock
PLXP
+$2.59M
5
PDLI
PDL BioPharma, Inc.
PDLI
+$2.16M

Sector Composition

1 Healthcare 87.1%
2 Technology 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$2.48M 0.51%
152,912
-22,953
27
$2.16M 0.44%
35
28
$2.01M 0.41%
9,276
+5,109
29
$1.94M 0.4%
+51,935
30
$1.27M 0.26%
791,870
-211,092
31
$190K 0.04%
10,107
32
– –
-15,000
33
– –
0
34
– –
-6,000
35
– –
0
36
– –
0
37
– –
-22,366
38
– –
0
39
– –
-22,619
40
– –
0
41
– –
-645,000
1
2